Figure 3. Kaplan-Meier estimation of A) 4-year relapse-free survival and B) 4-year distant metastasis-free survival in the intent-to-treat
population (data cutoff, April 30, 2018)
Figure 3. Kaplan-Meier estimation of A) 4-year relapse-free survival and B) 4-year distant metastasis-free survival in the intent-to-treat
population (data cutoff, April 30, 2018)